Ex Vivo Lung Perfusion - experimental and clinical studies
Sammanfattning
Background: Ex vivo lung perfusion (EVLP) has since its introduction in clinical practice
experienced a rapid expansion and made more organs available for transplantation. Different
protocols and strategies have been implemented at transplantation centres around the world. Aims: In an experimental setup in pigs, the effect of haemofiltration during EVLP on lung function,
perfusate oncotic pressure and lung weight (paper I), was evaluated, and two clinically used
strategies for EVLP were compared, with respect to lung function, metabolism, inflammatory
response, oxidative stress, and cell viability (paper II). To assess the clinical outcome of patients in
Gothenburg and Copenhagen undergoing lung transplantation after EVLP they were compared to
a contemporary control group (paper III). Correlations between lung physiologic variables during
EVLP and short-term clinical outcome in lung transplant recipients were assessed, with the intention
to identify variables during EVLP predicting post-transplantation outcome.
Methods: In paper I, pulmonary oedema was induced in pigs, and lungs randomized to EVLP with
or without haemofiltration. Oncotic pressure, lung performance and weight were measured before
and after EVLP. In paper II porcine lungs were harvested and randomized to EVLP according to
either of two clinically used protocols. The groups were compared before and after four hours of
EVLP. In paper III lungs not accepted for donation, but with potential for improvement, underwent
EVLP and were transplanted if predefined criteria were met. Outcome was compared to a control
group of patients transplanted with conventional donor lungs. Variables during EVLP were
examined for correlation with short-term outcome after lung transplantation in paper IV.
Results: Haemofiltration during EVLP increased oncotic pressure and decreased lung weight
compared to EVLP without haemofiltration, but without effect on lung oxygenation capacity in either
group (paper I). There was a trend towards more lung oedema formation in the acellular, open left
atrium group, but otherwise there were no differences between groups (paper II). Patients receiving
lungs after EVLP had a lower PaO2/FiO2 ratio at arrival in the intensive care unit (ICU), longer time
to extubation and spent longer time in ICU, however without difference in lung function at one year
or survival at intermediate follow-up (paper III). No correlations could be found between variables
measured during clinical EVLP and short-term outcome in lung transplant recipients (paper IV).
Conclusions: Haemofiltration during EVLP may decrease pulmonary oedema. No major
differences in effect could be established between the two clinically most used methods for EVLP.
Outcome in patients transplanted with lungs after EVLP was comparable to patients receiving
conventional lungs at intermediate-term follow-up. There were no clear correlations between
commonly measured variables during EVLP and short-term outcome.
Delarbeten
Article I: Hemofiltration in ex vivo lung perfusion - a study in experimentally induced
pulmonary edema.
T. Nilsson, C. Hansson, A. Wallinder, C-J Malm, M. Silverborn, S-E Ricksten, G. Dellgren.
The Journal of Thoracic and Cardiovascular Surgery. 2016;151(2):570-575. ::PMID::26219590 Article II: Comparison of two strategies for ex vivo lung perfusion.
T. Nilsson, J. F. Gielis, A. Slama, C. Hansson, A. Wallinder, S-E. Ricksten, G. Dellgren.
The Journal of Heart and Lung Transplantation. 2018;37(2):292-298. ::PMID::28756120 Article III: Lung transplantation after ex-vivo lung perfusion in two Scandinavian centres.
T. Nilsson, A. Wallinder, I. Henriksen, J. C. Nilsson, S-E. Ricksten, H. Møller-Sørensen, G.
Riise, M. Perch, G. Dellgren. Submitted only. Article IV. Correlation of factors during ex vivo lung perfusion with short-term outcome post
transplantation.
T. Nilsson, A. Wallinder, I. Henriksen, J. C. Nilsson, S-E. Ricksten, H. Møller-Sørensen, G.
Riise, M. Perch, G. Dellgren
In manuscript.
Examinationsnivå
Doctor of Philosophy (Medicine)
Universitet
University of Gothenburg. Sahlgrenska Academy
Institution
Institute of Clinical Sciences. Department of Anesthesiology & Intensive Care Medicine
Disputation
Fredagen den 25 maj 2018, klockan 9.00, Hörsal Arvid Carlsson, Academicum, Medicinaregatan 3, Göteborg
Datum för disputation
2018-05-25
E-post
drtobiasnilsson@gmail.com
Datum
2018-05-07Författare
Nilsson, Tobias
Nyckelord
EVLP
ex vivo lung perfusion
lung transplantation
Publikationstyp
Doctoral thesis
ISBN
978-91-629-0467-8 (Electronic edition)
978-91-629-0466-1 (Printed)
Språk
eng